Karur Vysya Bank jumps over 11% after June-quarter profit rises 45%

AI Market Summary
A cluster of Indian corporates reported strong June-quarter results, with notable profit and margin expansion at Karur Vysya Bank and CMPDI, resilient earnings at UltraTech Cement, and sharply improved profitability metrics at Paytm. Emcure added a regulatory catalyst via CDSCO approval for a new MASH indication. Broad intraday gains signal improving risk appetite and confidence in earnings durability, though the impact appears stock-specific rather than macro-wide.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-2.26%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Several Indian listed companies posted June-quarter 2024 results, with Karur Vysya Bank reporting a 45% year-on-year rise in net profit and CMPDI posting a 53.8% increase. UltraTech Cement’s net profit grew 17%, while One97 Communications (Paytm) reported profit after tax up 79%. Emcure Pharmaceuticals said CDSCO approved its co-marketed semaglutide brand Poviztra for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH). Shares of the companies moved higher intraday after the updates.